ASCENDIS PHARMA A/S (ASND)
Clinical trial NCT07264634 updates: 1. completion date: 2028-01-01 → 2027-08-01 2. primary completion date: 2028-01-01 → 2027-08-01
Clinical trial NCT07264634 updates: 1. completion date: 2028-01-01 → 2027-08-01 2. primary completion date: 2028-01-01 → 2027-08-01
Clinical trial NCT07313761 updates: 1. completion date: 2026-06-26 → 2026-07-02 2. primary completion date: 2026-06-26 → 2026-07-02
Clinical trial NCT07222384 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-31 → 2026-07-24 3. primary completion date: 2026-07-31 → 2026-07-24 4. enrollment: 343 → 344 participants
Clinical trial NCT06232512 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-12-01 → 2026-06-23 3. primary completion date: 2026-07-01 → 2026-06-23 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT05403710: collaborators added: AbbVie.
Clinical trial NCT07730450 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2027-08-06 → 2027-08-20 3. primary completion date: 2027-08-06 → 2027-08-20 4. masking: DOUBLE → NONE
Clinical trial NCT05502393 updates: 1. status: UNKNOWN → ACTIVE_NOT_RECRUITING 2. completion date: 2024-12-31 → 2027-12-31 3. primary completion date: 2024-07-31 → 2027-12-31 4. enrollment: 118 → 133 participants 5. enrollment type: ESTIMATED → ACTUAL 6. allocation: NA → NON_RANDOMIZED 7. masking: NONE → SINGLE
Clinical trial NCT07498335: status: NOT_YET_RECRUITING → RECRUITING.
Clinical trial NCT06577363 updates: 1. completion date: 2031-08-30 → 2028-06-30 2. primary completion date: 2031-08-30 → 2028-06-30
Clinical trial NCT04280081: completion date: 2027-11-01 → 2028-11-01.